We follow industry news and trends so you can stay ahead of the game. Subscribe to receive emails regarding policies and findings that impact you and your business.

Already a subscriber and want to update your preferences? Click here.

BACK TO EVENTS

EVENTS

WEBINARS

MAY 18 2021

Key Issues in Regenerative Medicine Regulation and Approval - FDLI Annual Conference

May 18 2021

2:45 PM - 3:45 PM

Barbara Binzak Blumenfeld, shareholder in the firm's Life Sciences Industry Group, is moderating a panel at the 2021 FDLI Annual Conference, “Key Issues in Regenerative Medicine Regulation and Approval.” The panel will address multiple regulatory aspects of regenerative medicine, from product characterization to product manufacturing to FDA enforcement.